Vimarsana
Biggest News Aggregation in the World

Affimed Lumin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Affimed Lumin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Affimed Lumin Today - Breaking & Trending Today

Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the ... - Vimarsana News

Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the ...

Published: September 12, 2023

AFM13 in combination with AlloNK® (also known as AB-101) will be investigated in the LuminICE-203 open-label, multi-center, multi-cohort, phase 2 study evaluating the efficacy and safety of the treatment in

Source: eagletribune.com
Related Topics:
Baden WübergNew YorkUnited StatesSan DiegoNicholas VeomettAlexander FudukidisWolfgang FischerArtiva BiotherapeuticsJessica YinglingMary Beth SandinAffimed LuminArtiva AlloGc Cell CorporationCorporate DevelopmentLittle Dog Communications IncUniversity Of Texas Md Anderson Cancer CenterChief Operating OfficerFast Track DesignationAccelerated ApprovalPriority ReviewBiologic License ApplicationNew Drug ApplicationFast TrackCancer Center
Affimed Says FDA Grants Fast Track Designation For AFM13 With AlloNK To Treat R/r Hodgkin Lymphoma - Vimarsana News

Affimed Says FDA Grants Fast Track Designation For AFM13 With AlloNK To Treat R/r Hodgkin Lymphoma

Published: September 12, 2023

Immuno-oncology company Affimed N.V. (AFMD) announced that the FDA has granted fast track designation to the combination of its innate cell engager (ICE) AFM13 with AlloNK for the potential treatment of relapsed/refractory (r/r) Hodgkin lymphoma (HL).

Source: rttnews.com
Related Topics:
Affimed LuminHodgkin LymphomaMmuno Oncology Company Affimed